• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

川崎病患者血清白细胞介素-10水平升高。

Increased serum interleukin-10 level in Kawasaki disease.

作者信息

Kim D S, Lee H K, Noh G W, Lee S I, Lee K Y

机构信息

Department of Pediatrics, Yonsei University College of Medicine, Seoul, Korea.

出版信息

Yonsei Med J. 1996 Apr;37(2):125-30. doi: 10.3349/ymj.1996.37.2.125.

DOI:10.3349/ymj.1996.37.2.125
PMID:8711935
Abstract

Serum IL-10 level in Kawasaki disease(KD) was tested. In the KD patients' sera during the acute phase, the levels of IL-10 were markedly elevated (122.0 +/- 39.1 pg/ml) compared to 3.7 +/- 1.7 pg/ml in the control subjects (p < 0.001). The serum IL-10 levels remained elevated in the subacute phase (16. 7 +/- 9.7 pg/ml, p < 0.001) and were restored to the normal levels(7.9 +/- 3.9 pg/ml) during the convalescent phase. In the patients with acute febrile disease, the serum IL-10 level increased significantly (34.4 +/- 14.1 pg/ml, p < 0.001) compared to that of the age-matched control subjects, but were not as high as in acute phase of KD(p < 0.005). This increase in serum IL-10 levels in KD may contribute to the up-regulation of humoral immunity and to the down-regulation of acute inflammation due to an increase in proinflammatory cytokines.

摘要

检测了川崎病(KD)患者的血清白细胞介素-10(IL-10)水平。在急性期KD患者的血清中,IL-10水平显著升高(122.0±39.1 pg/ml),而对照组为3.7±1.7 pg/ml(p<0.001)。在亚急性期血清IL-10水平仍升高(16.7±9.7 pg/ml,p<0.001),在恢复期恢复至正常水平(7.9±3.9 pg/ml)。在急性发热性疾病患者中,血清IL-10水平与年龄匹配的对照组相比显著升高(34.4±14.1 pg/ml,p<0.001),但不如KD急性期高(p<0.005)。KD患者血清IL-10水平的升高可能有助于体液免疫的上调以及由于促炎细胞因子增加导致的急性炎症的下调。

相似文献

1
Increased serum interleukin-10 level in Kawasaki disease.川崎病患者血清白细胞介素-10水平升高。
Yonsei Med J. 1996 Apr;37(2):125-30. doi: 10.3349/ymj.1996.37.2.125.
2
High levels of circulating interleukin-4 and interleukin-10 in Kawasaki disease.川崎病中循环白细胞介素-4和白细胞介素-10水平升高。
Int Arch Allergy Immunol. 1997 Feb;112(2):152-6. doi: 10.1159/000237447.
3
[Plasma interleukin-10 levels in Kawasaki disease].[川崎病患者血浆白细胞介素-10水平]
Arerugi. 1996 Apr;45(4):409-12.
4
[Circulating interleukin-4 levels in acute phase Kawasaki disease].[急性期川崎病患者循环白细胞介素-4水平]
Arerugi. 1996 Oct;45(10):1137-9.
5
Serum interleukin-6 in Kawasaki disease.川崎病中的血清白细胞介素-6
Yonsei Med J. 1992 Jun;33(2):183-8. doi: 10.3349/ymj.1992.33.2.183.
6
Interleukin-18 and coronary artery lesions in patients with Kawasaki disease.白介素-18 与川崎病患者冠状动脉病变。
J Chin Med Assoc. 2013 Aug;76(8):438-45. doi: 10.1016/j.jcma.2013.04.005. Epub 2013 Jun 13.
7
Serum levels of interleukin-18 are elevated in the subacute phase of kawasaki syndrome.川崎病亚急性期血清白细胞介素-18水平升高。
Int Arch Allergy Immunol. 2004 Oct;135(2):161-5. doi: 10.1159/000080660. Epub 2004 Sep 2.
8
[Value of serum soluble interleukin-2R, interleukin-6 and C-reactive protein in the early diagnosis of Kawasaki disease].[血清可溶性白细胞介素-2受体、白细胞介素-6及C反应蛋白在川崎病早期诊断中的价值]
Zhongguo Dang Dai Er Ke Za Zhi. 2006 Jun;8(3):208-10.
9
Serum soluble E-selectin levels in Kawasaki disease.川崎病患者血清可溶性E选择素水平
Scand J Rheumatol. 1994;23(5):283-6. doi: 10.3109/03009749409103730.
10
[Serum interleukin-2 receptor in patients with Kawasaki disease].[川崎病患者血清白细胞介素-2受体]
Arerugi. 1989 Jan;38(1):49-56.

引用本文的文献

1
Prediction Model for Diagnosis of Kawasaki Disease Using iTRAQ-Based Analysis.基于iTRAQ分析的川崎病诊断预测模型
Children (Basel). 2021 Jul 5;8(7):576. doi: 10.3390/children8070576.
2
Identifying Circulating MicroRNA in Kawasaki Disease by Next-Generation Sequencing Approach.通过下一代测序技术鉴定川崎病中的循环 microRNA。
Curr Issues Mol Biol. 2021 Jun 25;43(2):485-500. doi: 10.3390/cimb43020037.
3
Serum proteins may facilitate the identification of Kawasaki disease and promote in vitro neutrophil infiltration.
血清蛋白可能有助于川崎病的鉴定,并促进体外中性粒细胞浸润。
Sci Rep. 2020 Sep 24;10(1):15645. doi: 10.1038/s41598-020-72695-z.
4
Antibodies and Immunity During Kawasaki Disease.川崎病期间的抗体与免疫
Front Cardiovasc Med. 2020 May 28;7:94. doi: 10.3389/fcvm.2020.00094. eCollection 2020.
5
PGK1 as an immune target in Kawasaki disease.PGK1 作为川崎病的免疫治疗靶点。
Clin Exp Immunol. 2018 Dec;194(3):371-379. doi: 10.1111/cei.13204. Epub 2018 Oct 15.
6
ITPKC and SLC11A1 Gene Polymorphisms and Gene-Gene Interactions in Korean Patients with Kawasaki Disease.韩国川崎病患者中ITPKC和SLC11A1基因多态性及基因-基因相互作用
Yonsei Med J. 2018 Jan;59(1):119-127. doi: 10.3349/ymj.2018.59.1.119.
7
Losartan attenuates the coronary perivasculitis through its local and systemic anti-inflammatory properties in a murine model of Kawasaki disease.在川崎病小鼠模型中,氯沙坦通过其局部和全身抗炎特性减轻冠状动脉周围炎。
Pediatr Res. 2017 Apr;81(4):593-600. doi: 10.1038/pr.2016.266. Epub 2016 Dec 20.
8
Recent Advances in Kawasaki Disease.川崎病的最新进展
Yonsei Med J. 2016 Jan;57(1):15-21. doi: 10.3349/ymj.2016.57.1.15.
9
Etanercept suppresses arteritis in a murine model of kawasaki disease: a comparative study involving different biological agents.依那西普在川崎病小鼠模型中抑制动脉炎:一项涉及不同生物制剂的比较研究。
Int J Vasc Med. 2013;2013:543141. doi: 10.1155/2013/543141. Epub 2013 Mar 31.
10
Association of interleukin-10 A-592C polymorphism in Taiwanese children with Kawasaki disease.台湾川崎病儿童白细胞介素-10 A-592C多态性的关联研究
J Korean Med Sci. 2009 Jun;24(3):438-42. doi: 10.3346/jkms.2009.24.3.438. Epub 2009 Jun 12.